Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix

Cancer Letters

Volumn 229, Issue 2, 2005, Pages 245-252

  Castle, Philip E ^a   Ashfaq, Raheela ^b   Ansari, Faryal ^b   Muller, Carolyn Y ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical intraepithelial neoplasia; Heat shock proteins; HSP40; HSP60; HSP70; HSP90; Human papillomavirus (HPV); Immunohistochemistry

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90;

ARTICLE; CARCINOGENESIS; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 26444556837     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.06.045     Document Type: Article

References (25)

1. P. Moseley Stress proteins and the immune response Immunopharmacology 48 2000 299 302
2. A.G. Pockley Heat shock proteins as regulators of the immune response Lancet 362 2003 469 476
3. T. Lebret, R.W. Watson, V. Molinie, A. O'Neill, C. Gabriel, and J.M. Fitzpatrick Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma Cancer 98 2003 970 977
4. J.P. Geisler, J.E. Tammela, K.J. Manahan, H.E. Geisler, G.A. Miller, and Z. Zhou HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up Eur. J. Gynaecol. Oncol. 25 2004 165 168
5. G.O. Elpek, S. Karaveli, T. Simsek, N. Keles, and N.H. Aksoy Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries Acta Pathol. Microbiol. Scand. 111 2003 523 530
6. L.Y. Luo, I. Herrera, A. Soosaipillai, and E.P. Diamandis Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library Br. J. Cancer 87 2002 339 343
7. W. Hu, W. Wu, S.C. Yeung, R.S. Freedman, J.J. Kavanagh, and C.F. Verschraegen Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor Anticancer Res. 22 2002 665 672
8. D.R. Ciocca, G.M. Clark, A.K. Tandon, S.A. Fuqua, W.J. Welch, and W.L. McGuire Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications J. Natl. Cancer Inst. 85 1993 570 574
9. N. Vanmuylder, L. Evrard, P. Daelemans, J. Van Reck, and N. Dourov Expression of heat shock proteins in salivary gland tumors. Immunohistochemical study of HSP27, HSP70, HSP90, and HSP110: apropos of 50 cases Ann. Pathol. 20 2000 190 195
10. J. Chen, Q.Y. He, A.P. Yuen, and J.F. Chiu Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis Proteomics 4 2004 2465 2475
11. M.L. Lo, R. Leonardi, M.A. Mariggio, M.D. Mignogna, C. Rubini, and A. Vinella HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma Histol. Histopathol. 19 2004 119 128
12. C. Sarto, C. Valsecchi, F. Magni, L. Tremolada, C. Arizzi, and N. Cordani Expression of heat shock protein 27 in human renal cell carcinoma Proteomics 4 2004 2252 2260
13. F. Cappello, M. Bellafiore, A. Palma, V. Marciano, G. Martorana, and P. Belfiore Expression of 60-kD heat shock protein increases during carcinogenesis in the uterine exocervix Pathobiology 70 2002 83 88
14. R. Ralhan, and J. Kaur Differential expression of Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix Clin.Cancer Res. 1 1995 1217 1222
15. C.S. Park, I.S. Joo, S.Y. Song, D.S. Kim, D.S. Bae, and J.H. Lee An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix Gynecol. Oncol. 74 1999 53 60
16. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, and J. Peto Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group J. Natl. Cancer Inst. 87 1995 796 802
17. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, and K.V. Shah Epidemiologic classification of human papillomavirus types associated with cervical cancer N. Engl. J. Med. 348 2003 518 527
18. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
19. T.C. Wright Jr., and M. Schiffman Adding a test for human papillomavirus DNA to cervical-cancer screening N. Engl. J. Med. 348 2003 489 490
20. M.H. Stoler, and M. Schiffman Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study J. Am. Med. Assoc. 285 2001 1500 1505
21. R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, and U. Petry Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int. J. Cancer 92 2001 276 284
22. S.S. Wang, M. Trunk, M. Schiffman, R. Herrero, M.E. Sherman, and R.D. Burk Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica Cancer Epidemiol. Biomarkers Prev. 13 2004 1355 1360
23. F.W. King, A. Wawrzynow, J. Hohfeld, and M. Zylicz Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53 EMBO J. 20 2001 6297 6305
24. P.E. Castle, S.L. Hillier, L.K. Rabe, A. Hildesheim, R. Herrero, and M.C. Bratti An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV) Cancer Epidemiol. Biomarkers Prev. 10 2001 1021 1027
25. S.E.Hawes, N.B.Kiviat. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer?, J.Natl.Cancer Inst., 94, (2002) 1592-1593.